trial · primary record
Paclitaxel
Pancreatic Ductal Adenocarcinoma (PDAC)
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 10 |
| Primary completion | 2030-07-01 |
| Primary endpoint | Adverse event rate |
| Registry ID | NCT07030283 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:32.251Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07030283
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.